title: Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
abstract: In France, extra restrictions have been placed on this appetite-suppressant drug. Phentermine is widely used in many countries despite its multiple adverse effects and lack of proven efficacy in preventing complications of obesity.
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001069:Appetite Regulation / Q000187:drug effects; D004338:Drug Combinations; D004335:Drug and Narcotic Control; D019317:Evidence-Based Medicine; D005602:France; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D009294:Narcotics / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy* / Q000523:psychology; D010645:Phentermine / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D000077236:Topiramate; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects
chemical_list: D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D004338:Drug Combinations; D009294:Narcotics; D000077236:Topiramate; D005632:Fructose; D010645:Phentermine